Active Buzzers: Cisco Systems, Inc. (NASDAQ:CSCO), Arena Pharmaceuticals (NASDAQ:ARNA)

Pompano Beach, FL -- (SBWIRE) -- 01/15/2013 -- Cisco Systems, Inc. (NASDAQ:CSCO) previous month accomplished the takeover of cloud networking expert and leader Meraki Inc.

Furthermore, the firm is being sued in federal court by East Carolina University (ECU), which resists to Cisco's (CSCO) illegal use of ECU's federally registered trademark “Tomorrow Starts Here.”

What was Cisco response to such news? Find out here

Shares of Cisco (CSCO) were down -0.29% for the session to US$20.97 on above 55.16 million shares, in contrast to its average volume of 37.81 million shares. Cisco has shed almost 10 percent of its market share in network security over the previous five years to lesser, more creative opponents like Juniper Networks Inc, Checkpoint Systems Inc, and Palo Alto Networks Inc.

Cisco is well informed of the deficiency and has been aggressively looking for takeovers to strengthen its network security offerings for some time, according to three sources closely related with the issue.

Few of the Arena Pharmaceuticals’ (NASDAQ:ARNA) retail-investor stockholders blamed the US Drug Enforcement Agency of collaborating with Wall Street hedge funds to postpone the commercial release of the firm’s weight-loss pill Belviq.

The DEA is gathering public comments on its planned rule making Belviq a Schedule IV controlled substance.

The 30-day comment phase ends on Jan. 18, following which DEA would finalize its decision.

What will be the consequences if 30-day period ends for Arena? Find in this report

Following another 30-day waiting phase, the rule turns effective and Arena's marketing associate Eisai can start selling Belviq and start to contend against Vivus' (VVUS) Qsymia.

About No Limit Stocks
NOLIMITSTOCKS.com is made up of a team of professional analyst that possess over 30 years of expert, stock market experience. Our goal is to research thousands of companies and provide investors with the latest insights in the market with stocks that can make explosive profits. We study the hottest companies so you don't have to!

Our newsletter is always free to Join and offers a variety of useful investors tools that will help you break the limits! There will be no regrets!

Disclaimer
The assembled information disseminated by nolimitstocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. nolimitstocks.com does expect that investors will buy and sell securities based on information assembled and presented in nolimitstocks.com. PLEASE always do your own due diligence, and consult your financial advisor.